Caribou Biosciences Inc (CRBU)

08:52 AM

Caribou Biosciences Shares Double After Strong Multiple Myeloma Trial Results - MSN

08:52 AM

08:34 AM

Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments - MSN

08:34 AM

07:41 AM

Caribou Biosciences expects cash and marketable securities as of Sept 30 to be $159.2 million - MarketScreener

07:41 AM

07:37 AM

Caribou Biosciences Reports Positive ANTLER Phase 1 Results - TipRanks

07:37 AM

07:26 AM

Caribou Biosciences announces results from CaMMouflage Phase 1 trial - TipRanks

07:26 AM

07:14 AM

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma - The Manila Times

07:14 AM

07:11 AM

Caribou Biosciences stock soars after positive multiple myeloma therapy data By Investing.com - Investing.com Canada

07:11 AM

07:08 AM

Caribou Biosciences Soars Over 120%What's Driving The Rally? - Nasdaq

07:08 AM

07:05 AM

Caribou’s off-the-shelf CAR-T therapy shows promise in lymphoma study - statnews.com

07:05 AM

07:00 AM

Caribou (NASDAQ: CRBU): 51% 12-mo PFS with vispa-cel, on par with autologous CAR-T - Stock Titan

07:00 AM

06:01 AM

Why Caribou Biosciences Inc. stock remains on buy listsJuly 2025 PreEarnings & Fast Entry High Yield Tips - newser.com

06:01 AM

05:12 AM

Using Bollinger Bands to evaluate Caribou Biosciences Inc.2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com

05:12 AM

03:39 AM

What machine learning models say about Caribou Biosciences Inc.Weekly Profit Recap & Pattern Based Trade Signal System - newser.com

03:39 AM

01:52 AM

Published on: 2025-11-03 00:52:40 - newser.com

01:52 AM

01:45 AM

Is it time to cut losses on Caribou Biosciences Inc.Risk Management & Free Expert Verified Stock Movement Alerts - newser.com

01:45 AM

Nov 02, 2025

Caribou Biosciences to Host Webcast Reporting New Clinical Data for Anti-CD19 and Anti-BCMA CAR-T Cell Therapies - Quiver Quantitative

Nov 02, 2025

Nov 02, 2025

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma - The Manila Times

Nov 02, 2025

Nov 02, 2025

Caribou Bio (NASDAQ: CRBU) to host Nov. 3 webcast on first CB-011 data, vispa-cel update - Stock Titan

Nov 02, 2025

Nov 02, 2025

Ranking Caribou Biosciences Inc. among high performing stocks via tools2025 Geopolitical Influence & Daily Stock Trend Watchlist - newser.com

Nov 02, 2025

Nov 02, 2025

Risk adjusted return profile for Caribou Biosciences Inc. analyzedForecast Cut & Weekly Consistent Profit Watchlists - newser.com

Nov 02, 2025

Nov 02, 2025

Statistical indicators supporting Caribou Biosciences Inc.’s strengthCPI Data & Reliable Breakout Forecasts - newser.com

Nov 02, 2025

Nov 02, 2025

Will Caribou Biosciences Inc. stock go up soonGlobal Markets & Short-Term High Return Ideas - newser.com

Nov 02, 2025

Nov 01, 2025

Is Caribou Biosciences Inc. stock a contrarian buyEarnings Beat & High Accuracy Buy Signal Tips - newser.com

Nov 01, 2025

Oct 31, 2025

Caribou Biosciences Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView

Oct 31, 2025

Oct 31, 2025

Intraday pattern recognizer results for Caribou Biosciences Inc.2025 Valuation Update & Reliable Momentum Entry Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

Caribou Biosciences Advances CRISPR-Edited CAR-T Therapy in Lymphoma Study - TipRanks

Oct 30, 2025

Oct 30, 2025

Caribou Biosciences’ Long-Term Study: A Key Update for Investors - MSN

Oct 30, 2025

Oct 30, 2025

Caribou Biosciences (CRBU) to Release Quarterly Earnings on Wednesday - MarketBeat

Oct 30, 2025

Oct 30, 2025

Caribou Biosciences Expands Genetic Innovation In Biotech - Kalkine Media

Oct 30, 2025

Oct 29, 2025

Can swing trading help recover from Caribou Biosciences Inc. lossesPortfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com

Oct 29, 2025

Oct 29, 2025

Caribou Biosciences’ CRISPR-Edited CAR-T Therapy: A Promising Step in Multiple Myeloma Treatment - TipRanks

Oct 29, 2025